
WHO launches the first-ever trial of oral drug to prevent Bundibugyo Ebola in DR Congo
The World Health Organization (WHO) has launched the first-ever clinical trial of an antiviral drug to determine whether it can protect people from contracting the Bundibugyo strain of Ebola, which continues to spread in the Democratic Republic of the Congo (DRC).








